Nemaura Pharma moves forward with unique transdermal drug delivery technology

| By | Innovative Medicines, Medical Devices, Vaccines
0
259

scientist

UK biotech company Nemaura Pharma has spent several years working to transform the way drugs are delivered through the skin. The company has made significant progress in the reformulation of liquid vaccines administered through the skin using its solid dose delivery system, Micro-Patch™.

The device works by depositing the drug under the outer layer of the skin using a metal needle which then retracts completely, minimising the risk of stick injuries. The solid dose delivery device which has been designed for safe patient self-administration, has the potential to improve control over drug release and absorption, improve stability performance, and either partially, or completely, eliminate the cold storage requirements for vaccines and biologics.

Nemaura now has patents secured or pending across multiple patent families. The company came to the attention of global growth strategy analyst Frost & Sullivan in 2016, winning the F&S award for best practices in Enabling Technology Leadership in the Transdermal Drug Delivery Industry for the Micro-Patch delivery device.

Nemaura now has patents secured or pending across multiple patent families. The company came to the attention of global growth strategy analyst Frost & Sullivan in 2016, winning the F&S award for best practices in Enabling Technology Leadership in the Transdermal Drug Delivery Industry for the Micro-Patch delivery device. The work of founder Dr. Faz Chowdhury and his team of 35 scientists and technicians continues to attract interest from leading pharmaceutical companies.

Nemaura Pharma is a UK medical technology company, and a finalist in the Medilink UK industry awards having received the Medilink East Midlands Innovation award for its unique transdermal drug delivery technologies. Micro-Patch provides a highly consistent and effective method for better delivery of biologics and vaccines through the skin using a low cost disposable device.

SOURCE: nemaura
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.